Dr. Edoardo Marcora

Computational biology, software development, and genetics expertise

Highlights

  • Professor of Genetics, Genomic Sciences, and Neuroscience, Mount Sinai Icahn School of Medicine; member of the Icahn Genomics Institute.
  • Former Principal Scientist at Amgen.
  • 30+ peer-reviewed publications and patents on the genetics and network biology of neurodegeneration.

Biography

Dr. Edoardo Marcora has a strong academic and industry background in experimental and computational biology, neuroscience, human genetics, functional genomics, software development, and drug discovery. Throughout his graduate training at the University of Colorado at Boulder and his post-doctoral training at the California Institute of Technology (Caltech), he has investigated the role of transcription factors in neurodegeneration using various experimental and computational approaches. While on sabbatical at the European Bioinformatics Institute, he co-developed BioMart, a computational tool for genomic data integration and mining. As a Principal Investigator in the Department of Neuroscience Discovery at Amgen, he led and supported cross-functional teams identifying and validating drug targets for Alzheimer’s disease using human genetics, systems biology, and experimental biology approaches. Throughout his career, Edoardo has pioneered the use of systems genetics and integrative genomics coupled with targeted genome editing and high-content screening for the identification and validation of novel genetic risk factors and drug targets for Alzheimer’s disease.

Colleagues

Portrait of Dr. Robert Fremeau

Dr. Robert Fremeau

Founder and CEO

Experienced R&D; leader with 20+ years of experience in academia and industry.

Portrait of Dr. Maya Gosztyla

Dr. Maya Gosztyla

Co-founder and CSO

Neurobiologist with 5+ years of experience in cortical organoid disease models and applications of bioinformatics/machine learning in drug discovery.

Portrait of Dr. Alysson Muotri

Dr. Alysson Muotri

Stem cell and brain organoid pioneer

Created the first human organoid models for neurodevelopmental disorders.

Portrait of Dr. James Treanor

Dr. James Treanor

Experienced biotech C-suite officer

Current BOD, SAB member, and former CEO at ADRx, Inc.

Portrait of Dr. Mark H. Norman

Dr. Mark H. Norman

Innovative medicinal chemist

30+ years of drug discovery and development experience.

Portrait of Dr. Blake Anson

Dr. Blake Anson

Business development professional with deep commercial experience

19+ years building new markets and driving paradigm-shifting tools into biopharma, government, and academic organizations.

Get in touch

Talk to us about our precision neuroscience platform, our Parkinson’s disease program, or working with the BrainStorm team.

Robert.fremeau@brainstormtherapeutics.org818-584-4788

Get in touch
$99 once · free changesPreview reserved until Dec 1, 17:34 UTC
Buy this siteRequest a changeEdit it yourselfTerms